Increased carotid intima-media thickness in the absence of atherosclerotic plaques in an adult population with Fabry disease

Acta Paediatrica, International Journal of Paediatrics

Volumn 95, Issue SUPPL. 451, 2006, Pages 63-68

  Barbey, Frédéric ^a   Brakch, Noureddine ^a   Linhart, Aleš ^b   Jeanrenaud, Xavier ^a   Palecek, Thomas ^b   Bultas, Jan ^b   Burnier, Michel ^a   Hayoz, Daniel ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Atherosclerotic plaque; Fabry disease; Intima media thickness; Ultrasound

Indexed keywords

ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CIGARETTE SMOKING; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; ECHOGRAPHY; FABRY DISEASE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTIMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THICKNESS; TUNICA MEDIA;

ADULT; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; FABRY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; TUNICA INTIMA; TUNICA MEDIA;

EID: 33646691525     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1080/08035320600618924     Document Type: Conference Paper

References (36)

1. Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L. Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency. N Engl J Med 1967;276:1163-7.
2. Boutouyrie P, Laurent S, Laloux B, Lidove O, Grunfeld JP, Germain DP. Arterial remodelling in Fabry disease. Acta Paediatr 2002;91(Suppl 439):62-6.
3. Pfeilschifter J, Huwiler A. Ceramides as key players in cellular stress response. News Physiol Sci 2000;15:11-5.
4. Bots ML, Dijk JM, Oren A, Grobbee DE. Carotid intima-media thickness, arterial stiffness and risk of cardiovascular disease: current evidence. J Hypertens 2002;20:2317-25.
5. Cheng KS, Mikhailidis DP, Hamilton G, Seifalian AM. A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors. Cardiovasc Res 2002;54:528-38.
6. Mowbray PI, Lee AJ, Fowkes GR, Allan PL. Cardiovascular risk factors for early carotid atherosclerosis in the general population: the Edinburgh Artery Study. J Cardiovasc Risk 1997;4:357-62.
7. Mannami T, Baba S, Ogata J. Strong and significant relationships between aggregation of major coronary risk factors and the acceleration of carotid atherosclerosis in the general population of a Japanese city: the Suita Study. Arch Intern Med 2000;160:2297-303.
8. Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palu C, et al. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens 1998;16:949-61.
9. Yokoyama H, Aoki T, Imahori M, Kuramitsu M. Subclinical atherosclerosis is increased in type 2 diabetic patients with microalbuminuria evaluated by intima-media thickness and pulse wave velocity. Kidney Int 2004;66:448-54.
10. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997;96:1432-7.
11. Bots ML, Witteman JC, Grobbee DE. Carotid intima-media wall thickness in elderly women with and without atherosclerosis of the abdominal aorta. Atherosclerosis 1993;102:99-105.
12. Polak JF, O'Leary DH, Kronmal RA, Wolfson SK, Bond MG, Tracy RP, et al. Sonographic evaluation of carotid artery atherosclerosis in the elderly: relationship of disease severity to stroke and transient ischemic attack. Radiology 1993;188:363-70.
13. Wofford JL, Kahl FR, Howard GR, McKinney WM, Toole JF, Crouse JR, 3rd. Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis. Arterioscler Thromb 1991;11:1786-94.
14. Desnick RJ, Dean KJ, Grabowski G, Bishop DF, Sweeley CC. Enzyme therapy in Fabry disease: differential in vivo plasma clearance and metabolic effectiveness of plasma and splenic alpha-galactosidase A isozymes. Proc Natl Acad Sci USA 1979;76:5326-30.
15. Lyon MF. X-chromosome inactivation and human genetic disease. Acta Paediatr 2002;91(Suppl 439):107-12.
16. Barbey F, Haesler E, Teta D, Wicky S, Theytaz J, Hayoz D. Severity of macrovascular involvement in Fabry disease: is there a correlation with interventricular septum thickness? Acta Paediatr 2002;91(Suppl 439):132.
17. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997;146:483-94.
18. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK, Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999;340:14-22.
19. Vasankari T, Ahotupa M, Toikka J, Mikkola J, Irjala K, Pasanen P, et al. Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower levels of oxidized LDL with statin therapy. Atherosclerosis 2001;155:403-12.
20. Mack WJ, LaBree L, Liu C, Selzer RH, Hodis HN. Correlations between measures of atherosclerosis change using carotid ultrasonography and coronary angiography. Atherosclerosis 2000;150:371-9.
21. MacDermot KD, Holmes A, Miners AH. Natural history of Fabry disease in affected males and obligate carrier females. J Inherit Metab Dis 2001;24 Suppl 2:13-4.
22. MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 2001;38:769-75.
23. Becker AE, Schoorl R, Balk AG, van der Heide RM. Cardiac manifestations of Fabry's disease. Report of a case with mitral insufficiency and electrocardiographic evidence of myocardial infarction. Am J Cardiol 1975;36:829-35.
24. Mehta J, Tuna N, Moller JH, Desnick RJ. Electrocardiographic and vectorcardiographic abnormalities in Fabry's disease. Am Heart J 1977;93:699-705.
25. Kampmann C, Wiethoff CM, Perrot A, Beck M, Dietz R, Osterziel KJ. The heart in Anderson Fabry disease. Z Kardiol 2002;91:786-95.
26. Isaaz K. Tissue Doppler imaging for the assessment of left ventricular systolic and diastolic functions. Curr Opin Cardiol 2002;17:431-42.
27. Linhart A, Palecek T, Bultas J, Ferguson JJ, Hrudova J, Karetova D, et al. New insights in cardiac structural changes in patients with Fabry's disease. Am Heart J 2000;139:1101-8.
28. Elliott PM, Kindler H, Shah JS, Sachdev B, Rimoldi O, Thaman R, et al. Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase A. Heart 2006:92:357-60.
29. Mehta A, Ricci R, Widmer U, Dehout F, Garcia de Lorenzo A, Kampmann C, et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 2004;34:236-42.
30. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-41.
31. Bodary PF, Shen Y, Vargas FB, Bi X, Ostenso KA, Gu S, et al. Alpha-galactosidase A deficiency accelerates atherosclerosis in mice with apolipoprotein E deficiency. Circulation 2005;111:629-32.
32. Elleder M. Sequelae of storage in Fabry disease - pathology and comparison with other lysosomal storage diseases. Acta Paediatr Suppl 2003;92:46-53.
33. Watanabe S, Okura T, Kitami Y, Hiwada K. Carotid hemodynamic alterations in hypertensive patients with insulin resistance. Am J Hypertens 2002;15:851-6.
34. Vemmos KN, Tsivgoulis G, Spengos K, Papamichael CM, Zakopoulos N, Daffertshofer M, et al. Common carotid artery intima-media thickness in patients with brain infarction and intracerebral haemorrhage. Cerebrovasc Dis 2004;17:280-6.
35. Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For End-point reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:1004-10.
36. Schrader J, Rothemeyer M, Luders S, Kollmann K. Hypertension and stroke-rationale behind the ACCESS trial. Acute Candesartan Cilexetil Evaluation in Stroke Survivors. Basic Res Cardiol 1998;93 (Suppl 2):69-78.